SOP Guide for Pharma

Sterile Injectable Manufacturing: SOP for Sampling Procedures during Manufacturing – V 2.0

Sterile Injectable Manufacturing: SOP for Sampling Procedures during Manufacturing – V 2.0

Standard Operating Procedure for Sampling Procedures during Manufacturing


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/074/2025
Supersedes SOP/SIM/074/2022
Page No. Page 1 of 13
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

To establish a standardized method for the collection of representative samples during various stages of sterile injectable manufacturing for testing and evaluation, ensuring regulatory compliance and product quality.

2. Scope

This SOP applies to all sterile injectable manufacturing activities at [Insert Company Name] where in-process, intermediate, and finished product

samples are collected for analysis and quality evaluation.

3. Responsibilities

  • Production Officer: Responsible for collecting samples as per defined plan.
  • IPQA Officer: Verifies correct sampling, labels, and documentation.
  • QC Analyst: Receives samples and performs required tests.

4. Accountability

The Head – Quality Assurance is accountable for overall compliance and ensuring sampling procedures are followed during manufacturing operations.

5. Procedure

5.1 Sampling Plan

  1. Sampling must be performed based on approved sampling plan and batch manufacturing record (BMR).
  2. Sampling stages may include:
    • Raw material sampling
    • In-process bulk sampling
    • Post-filtration sample
    • Finished product sample
    • Environmental and rinse water sample

5.2 Sample Collection Procedure

  1. Ensure clean and sterile containers for sample collection.
  2. Use sterile tools (pipettes, sampling needles) and handle with gloves.
  3. Label each sample immediately with:
    • Batch No.
    • Sample Type
    • Date/Time
    • Sampler Name
  4. Enter sample details in the Sampling Logbook (Annexure-1).
  5. Transfer the samples promptly to the Quality Control laboratory.

5.3 Sample Labeling

  1. Use pre-printed or computer-generated labels where applicable.
  2. Ensure clear legibility and tamper-evident labeling.

5.4 Sampling Precautions

  1. Do not sample from damaged or leaking containers/vials.
  2. Ensure aseptic techniques are used during all sampling.
  3. Avoid cross-contamination between samples.

5.5 Sample Quantities

  1. Follow BMR or SOP-defined quantity for each sample type.
  2. Minimum quantity must be sufficient for complete testing and retention sample (if applicable).

5.6 Documentation

  1. All samples must be recorded in the Sampling Logbook and annexure forms.
  2. Details to be entered include:
    • Date and Time
    • Sampler Name
    • Batch and Sample Details

6. Abbreviations

  • SOP: Standard Operating Procedure
  • IPQA: In-Process Quality Assurance
  • QC: Quality Control
  • BMR: Batch Manufacturing Record

7. Documents

  1. Sampling Logbook – Annexure-1
  2. Sample Label Template – Annexure-2
  3. Sample Transfer Form – Annexure-3

8. References

  • WHO TRS 986 Annex 2: GMP for Sterile Products
  • ICH Q7: GMP for Active Pharmaceutical Ingredients
  • 21 CFR Part 211 – Current Good Manufacturing Practice

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Sampling Logbook

Date Batch No. Sample Type Quantity Sampler Name Remarks
18/06/2025 INJ-BT-3021 In-process 20 mL Rajesh Kumar Complies

Annexure-2: Sample Label Template

Label Field Example Entry
Sample Type Bulk Solution
Batch No. INJ-BT-3021
Date 18/06/2025
Sampler Sunita Reddy

Annexure-3: Sample Transfer Form

Date Sample Type Transferred By Received By QC Comments
18/06/2025 Post-filtration Rajesh Kumar Vinay Pawar Accepted

Revision History

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial Issue New SOP QA Head
18/06/2025 2.0 Updated documentation and annexures Periodic Review QA Head
Exit mobile version